HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use GENOTROPIN safely and effectively. See full prescribing information for GENOTROPIN
GENOTROPIN® (somatropin) for injection, for subcutaneous use
Initial U.S. Approval: 1987
INDICATIONS AND USAGE
GENOTROPIN is a recombinant human growth hormone indicated for:
DOSAGE AND ADMINISTRATION
GENOTROPIN should be administered subcutaneously (2)
DOSAGE FORMS AND STRENGTHS
GENOTROPIN lyophilized powder in a two-chamber color-coded cartridge (3):
GENOTROPIN MINIQUICK Growth Hormone Delivery Device containing a two-chamber cartridge (without preservative):
WARNINGS AND PRECAUTIONS
Other common somatropin-related adverse reactions include injection site reactions/rashes and lipoatrophy (6.1) and headaches (6.3).
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
See 17 for PATIENT COUNSELING INFORMATION.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.